Compounds · Other compounds · continued

Research-use-only status: what it means legally and practically — a second dataset posts 121–126

Compounds › Other compounds research use only mislabelling needs a source custom synthesis Solved

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.

dr_bhattacharyaTL3Physician21 Mar 2025#121

Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have happened in real people, not because of prudishness.

I checked the source rather than the summary, and they differ.

0 likes 16mo

t.duarteTL222 Mar 2025#122

Post #118 and I disagree about the size of the effect, not about the direction.

The failure mode on Research-use-only status is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.

2 likes 16mo

e.ferreiraTL3Regular23 Mar 2025#123

Post #121 answers the question as asked. The question underneath it is different.

Research-use-only status is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.

8 likes 16mo

h.falkTL224 Mar 2025 · edited#124

t.karlsen, post #107: I have no financial interest in anything named in this thread and I want to say so before I comment on Research-use-only status, because it is the sort of subject where it matters. Go to post

Good question, well framed, and I would like to see it answered properly.

20 likes in reply to #107 16mo

r.aldana_pharmdTL4Pharmacist25 Mar 2025#125

m.ibarra, post #24: Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its neighbours here. A weak preference rather than a position. Go to post

This follows post #123 rather than contradicting it.

Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its neighbours here.

I would not lead a decision with this, but I would not ignore it either.

0 likes in reply to #24 16mo

s.okaforTL226 Mar 2025#126

Worth separating two things that post #122 runs together.

I would call the community position on Research-use-only status likely rather than established, and I would be comfortable defending that hedge.

0 likes 16mo

Suggested topics

Topic	Participants	Replies	Views	Activity
About the Other compounds category Compounds › Other compounds research use only custom synthesis needs a source Pinned Wiki Closed Anything not covered by a dedicated subcategory, including research-use-only material with no human data. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…	+8	12	51k	7mo
Coming back to: When "no data" is the complete and final answer Compounds › Other compounds research use only needs a source custom synthesis When "no data" is the complete and final answer I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about the compound itself rather than about a trial of it. I…	+77	82	12k	11mo
Sequence verification for an obscure compound: how it is done — what changed since Compounds › Other compounds custom synthesis needs a source mislabelling On the subject in the title: Sequence verification for an obscure compound: how it is done — what changed since Working notes rather than a conclusion. What changes if the standard account of Sequence…	+100	108	1.3k	8mo
Research-use-only status: what it means legally and practically Compounds › Other compounds research use only custom synthesis needs a source mislabelling Research-use-only status: what it means legally and practically Writing it up because I had to work it out twice and would rather nobody else did. Asking about research-use-only status directly, because I…	+72	81	44k	1d
AOD-9604 and the fragment hypothesis, revisited Compounds › Other compounds mislabelling research use only custom synthesis needs a source Posting this under the heading it deserves: AOD-9604 and the fragment hypothesis, revisited Everything below is what sits behind that. Reading back through what has been written here about AOD-9604, three…	+40	44	2.8k	6mo

Related topics — sharing the tags research use only, mislabelling, needs a source

Topic	Participants	Replies	Views	Activity
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Sourcing › Regulatory FDA EMA compounding research use only Closed On the subject in the title: Revisiting: Why a compound being unapproved is not the same as being illegal to possess Working notes rather than a conclusion. I would like to know what people here actually do…	+76	82	52k	11mo
Labelling requirements for research chemicals — the long version Sourcing › Regulatory MHRA research use only compounding personal import Posting this under the heading it deserves: Labelling requirements for research chemicals — the long version Everything below is what sits behind that. A narrow question about Labelling requirements for…		2	1.8k	2mo
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Compounds › Secretagogues & GH axis CJC-1295 ipamorelin tesamorelin needs a source On the subject in the title: Evidence quality in the secretagogue literature: an honest assessment Working notes rather than a conclusion. A follow-up question about Evidence quality that I did not know to…	+20	24	18k	4mo
Reading a supplier's product description as a marketing document Compounds › Other compounds custom synthesis needs a source mislabelling On the subject in the title: Reading a supplier's product description as a marketing document Working notes rather than a conclusion. Documentation question rather than a pharmacological one, but about this…	+86	97	62k	8mo
Documenting a payment dispute without naming and shaming — the long version Sourcing › Payments documentation quality payments research use only Posting this under the heading it deserves: Documenting a payment dispute without naming and shaming — the long version Everything below is what sits behind that. A narrow question about Documenting a payment…		2	32k	1mo